— OPINION — In early December 2024 the FDA stated: “The FDA and CDC, in collaboration with state and local partners are investigating illnesses in a multistate outbreak of E. coli O157:H7 infections linked to an iceberg and romaine lettuce blend served at catering events, restaurants, and a school. Based on epidemiological information collected by CDC, a total of 69 people infected with the same strain of E.
coli O157 have been reported from 10 states. FDA’s traceback investigation has identified an iceberg and romaine lettuce blend from a common supplier as the source of this outbreak; however, impacted product identified to date appears to be past shelf life and no longer on the market. FDA is continuing to work with the supplier to determine if any additional product could be impacted.
At this time, there does not appear to be any ongoing risk to public health and there is no recommendation for consumers to avoid iceberg or romaine lettuce. FDA’s investigation is ongoing, and more information will be provided as it becomes available.” Today the FDA quietly announced that the outbreak – linked to romaine lettuce – had ended with 88 sick (nearly a 20 person increase) after traceback, inspection and testing was initiated.
The clear multistate E. coli outbreak linked to romaine lettuce raises concern about the FDA and transparency — the failure to disclose where consumers purchased the tainted product and who the FDA traced the romaine lettuce back to where t.